Stockscreener 앱 받기
1.80
3.45%
0.06
전일 마감가:
$1.74
열려 있는:
$1.75
하루 거래량:
283.19K
Relative Volume:
0.50
시가총액:
$67.58M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+11.11%
1개월 성능:
+1.12%
6개월 성능:
+6.51%
1년 성능:
-45.45%
1일 변동 폭
$1.75
$1.845
1주일 범위
$1.59
$1.845
52주 변동 폭
$1.23
$4.00
Metagenomi Inc Stock (MGX) Company Profile
명칭
Metagenomi Inc
전화
(510) 871-4880
주소
5959 HORTON STREET, EMERYVILLE
MGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
1.80 | 65.33M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-07 | 개시 | H.C. Wainwright | Buy |
| 2024-05-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-03-05 | 개시 | BMO Capital Markets | Outperform |
| 2024-03-05 | 개시 | Chardan Capital Markets | Buy |
| 2024-03-05 | 개시 | JP Morgan | Overweight |
| 2024-03-05 | 개시 | Jefferies | Buy |
| 2024-03-05 | 개시 | TD Cowen | Outperform |
| 2024-03-05 | 개시 | Wells Fargo | Overweight |
모두보기
Metagenomi Inc 주식(MGX)의 최신 뉴스
Is Metagenomi Inc. stock attractive after correctionHigh Beta Stocks & Maximize ROI With Proven Growth Stocks - ulpravda.ru
Will Metagenomi Inc. stock attract ESG investors2026 world cup usa national team final top scorers transition play group prediction expert opinion - ulpravda.ru
Metagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Aug Fed Impact: Is Metagenomi Inc stock undervalued vs historical averagesCEO Change & Reliable Breakout Forecasts - moha.gov.vn
Head to Head Survey: Madrigal Pharmaceuticals (NASDAQ:MDGL) vs. Metagenomi (NASDAQ:MGX) - Defense World
Short Interest in Metagenomi, Inc. (NASDAQ:MGX) Grows By 27.1% - Defense World
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock - Investing.com
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock By Investing.com - Investing.com UK
Metagenomi Earnings Notes - Trefis
CEO Moves: Can Metagenomi Inc stock weather global recession2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - moha.gov.vn
Why analysts upgrade Metagenomi Inc. stock2025 Price Targets & High Win Rate Trade Alerts - Улправда
Why Metagenomi Inc. stock attracts global investorsJuly 2025 Weekly Recap & Real-Time Market Trend Scan - Улправда
Is Metagenomi Inc. stock in correction or buying zoneMarket Risk Report & Community Shared Stock Ideas - bolumsonucanavari.com
Is Metagenomi Inc. stock recession proofJuly 2025 Summary & High Accuracy Investment Entry Signals - Улправда
Is Metagenomi Inc. stock positioned well for digital economy2025 Technical Patterns & Expert Approved Trade Ideas - DonanımHaber
Metagenomi, Inc. (NASDAQ:MGX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Thomas Brian C. sells $6786 in Metagenomi (MGX) stock By Investing.com - Investing.com Australia
Irish Jian, Metagenomi CEO, sells $2838 in MGX stock - Investing.com India
Metagenomi CFO Wapnick sells $2792 in shares By Investing.com - Investing.com Australia
Irish Jian, Metagenomi CEO, sells $2838 in MGX stock By Investing.com - Investing.com Australia
Metagenomi general counsel Wein sells $352 in stock By Investing.com - Investing.com Nigeria
Thomas Brian C. sells $6786 in Metagenomi (MGX) stock - Investing.com
Metagenomi general counsel Wein sells $352 in stock - Investing.com
Will Metagenomi Inc. stock deliver consistent dividendsBull Run & Technical Pattern Based Signals - Newser
Pura Vida Investments LLC Grows Stock Position in Metagenomi, Inc. $MGX - MarketBeat
Metagenomi’s general counsel Wein sells $360 in stock - Investing.com India
Metagenomi’s general counsel Wein sells $360 in stock By Investing.com - Investing.com Nigeria
Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 By Investing.com - Investing.com Canada
Metagenomi CFO Wapnick sells $2852 in shares By Investing.com - Investing.com Canada
Thomas Brian C. sells Metagenomi (MGX) shares worth $4888 - Investing.com India
Metagenomi CFO Wapnick sells $2852 in shares - Investing.com
CEO Irish Surrenders 1,602 Of Metagenomi Inc [MGX] - TradingView
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference - marketscreener.com
Metagenomi (Nasdaq: MGX) to unveil APOC3 preclinical data from Ionis collaboration at 2025 Nature conference - Stock Titan
Metagenomi Inc (MGX) 재무 분석
Metagenomi Inc (MGX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):